Moving Helicobacter pylori vaccine development forward with bioinformatics and immunomics

Expert Review of Vaccines

Volumn 11, Issue 9, 2012, Pages 1031-1033

  Moise, Leonard ^a,c   Moss, Steven F ^b,d   De Groot, Anne S ^a,c  

^a EpiVax Inc   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

bioinformatics; genomics; Helicobacter pylori; immunoinformatics; T cell epitope; vaccine

Indexed keywords

BEXSERO; EPITOPE; HELICOBACTER PYLORI VACCINE; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BIOINFORMATICS; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION PREVENTION; MENINGOCOCCOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

BACTERIAL VACCINES; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84869431336     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.80     Document Type: Review

References (18)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med. 362(17), 1597-1604 (2010
2. Megraud F, Coenen S, Versporten A et al.; on behalf of the Study Group participants. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut doi:10.1136/ gutjnl-2012-302254 (2012) (Epub ahead of print
3. Committee to Study Priorities for Vaccine Development. Vaccines for the 21st Century: A Tool for Decision Making. Stratton KR, Durch JS, Lawrence RS (Eds). National Academies Press, Washington, DC, USA, 181-188 (2000
4. Sayi A, Kohler E, Toller IM et al. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J. Immunol. 186(2), 878-890 (2011
5. Lefébure T, Bitar PD, Suzuki H, Stanhope MJ. Evolutionary dynamics of complete Campylobacter pan-genomes and the bacterial species concept. Genome Biol. Evol. 2, 646-655 (2010
6. Bevan MJ. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4(8), 595-602 (2004
7. Bachmann MF, Wolint P, Schwarz K, Oxenius A. Recall proliferation potential of memory CD8+ T cells and antiviral protection. J. Immunol. 175, 4677-4685 (2005
8. Edghill-Smith Y, Golding H, Manischewitz J et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11(7), 740-747 (2005
9. Rappuoli R, Covacci A. Reverse vaccinology and genomics. Science 302(5645), 602 (2003
10. He Y, Rappuoli R, De Groot AS, Chen RT. Emerging vaccine informatics. J. Biomed. Biotechnol. 2010, 218590 (2010
11. Taneja V, David CS. HLA class II transgenic mice as models of human diseases. Immunol. Rev. 169, 67-79 (1999
12. Moise L, McMurry JA, Pappo J et al. Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori. Hum. Vaccin. 4(3), 219-223 (2008
13. Moss SF, Moise L, Lee DS et al. HelicoVax: Epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine 29(11), 2085-2091 (2011
14. Lathrop SK, Bloom SM, Rao SM et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368), 250-254 (2011
15. Gregory SH, Mott S, Phung J et al. Epitopebased vaccination against pneumonic tularemia. Vaccine 27(39), 5299-5306 (2009
16. Moise L, Buller RM, Schriewer J et al. VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. Vaccine 29(3), 501-511 (2011
17. Alexander J, Bilsel P, del Guercio MF et al. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine 28(3), 664-672 (2010
18. Botten J, Whitton JL, Barrowman P et al. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans. J. Virol. 84(19), 9947-9956 (2010